---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-25-000074"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-17T00:04:15.645116+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Haemonetics announces Q2 FY2026 results; no figures in provided text

## Summary
- The company issued a press release on November 6, 2025 for its second quarter ended September 27, 2025.
- First half fiscal 2026 results are also included in the release.
- Specific financial results (revenue, EPS, etc.) are not available in the excerpt provided here.

## SEC filing metadata
- accession: 0000313143-25-000074
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314325000074/0000313143-25-000074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314325000074/hae-20251106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-25-000074
- JSON: https://secwatch.observer/filing/0000313143-25-000074.json
- Plain text: https://secwatch.observer/filing/0000313143-25-000074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.